secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2023-03-16T23:59:59+00:00
Accession:  0001104659-23-032986
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liquidia reports FY 2022 revenue $15.9M, net loss $41.0M; YUTREPIA launch path by H1 2024
--------------------------------------------------------------------------------

- Revenue $15.9M (+23% YoY); net loss $41.0M ($0.67/share) vs $34.6M loss in 2021.
- Legal resolution for YUTREPIA expected late 2023 to H1 2024; PTAB invalidated '793 patent.
- Cash $93.3M at Dec 31, 2022; HCRx revenue interest financing up to $100M ($32.5M funded).
- New CEO, CMO, Head of Sales; collaboration with Mainbridge for repurposed infusion pump.
- Amended Sandoz promotion agreement extends to 2032; pump repair costs split equally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465923032986/0001104659-23-032986-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465923032986/tm239718d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-032986

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer